Details
Stereochemistry | UNKNOWN |
Molecular Formula | C17H18N2 |
Molecular Weight | 250.3382 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1=CC=CC=C1)NC(C#N)C2=CC=CC=C2
InChI
InChIKey=NFHVTCJKAHYEQN-UHFFFAOYSA-N
InChI=1S/C17H18N2/c1-14(12-15-8-4-2-5-9-15)19-17(13-18)16-10-6-3-7-11-16/h2-11,14,17,19H,12H2,1H3
Amphetaminil is chemically an alpha-phenyl-alpha-[(1-methyl-2-phenyl)-ethylamino]-acetonitrile (1), i.e. a derivative of alpha-aminonitrile. It was was developed in the 1970s in Germany and marketed under the brand name Aponeuron. Administration of Aponeuron proved useful in the treatment of children with hyperkinetic syndrome. The subtle and crude motorics improved, symptoms of hyperactivity disappeared and the general school performance of the child improved. Aponeuron was also used in the treatment of disorders of erectile potency, chronic schizophrenia and narcolepsy. In 1974 amphetaminil was included in the class of addictives or habit-forming drugs, although prescription of the drug is not requiring adherence to strict requirements. Nevertheless, it has largely been withdrawn from clinical use.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m1850
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | Merck Index | ||
|
241-560-8
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
100000087198
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
17590-01-1
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
17813
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | RxNorm | ||
|
67172
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
28615
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
AMPHETAMINIL
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
SUB05419MIG
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
C74237
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
4471
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104064
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
DTXSID80864783
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
196
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY | |||
|
0XU0V77JVE
Created by
admin on Sat Dec 16 17:29:19 GMT 2023 , Edited by admin on Sat Dec 16 17:29:19 GMT 2023
|
PRIMARY |
ACTIVE MOIETY